StonvexLoading…
StonvexStonvexStonvexCore line items from SPHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 |
|---|---|---|---|---|
Revenue | $1.22B | $534.76M | $1.02B | $571.22M |
Operating Income | $-229.56M | $-260.56M | $-341.24M | $-273.04M |
Net Income | $33.41M | $-231.23M | $-200.65M | $502.77M |
EPS (Diluted) | $0.74 | $-6.45 | $-5.68 | $14.40 |
Total Assets | $4.21B | $4.52B | $4.79B | $4.97B |
Total Liabilities | $1.98B | $2.31B | $2.37B | $2.39B |
Cash & Equivalents | $521.26M | $501.95M | $573.23M | $131.97M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 45.30M | 35.86M | 35.30M | 34.93M |